Establishment of liver tumor cell lines from atherogenic and high fat diet fed hepatitis C virus transgenic mice
Abstract A syngeneic mouse model bearing a transplanted tumor is indispensable for the evaluation of the efficacy of immune checkpoint inhibitors (ICIs). However, few syngeneic mouse models of liver cancer are available. We established liver tumor cell lines (MHCF1 and MHCF5) from hepatitis C virus...
Guardado en:
Autores principales: | Takayoshi Shirasaki, Kazuhisa Murai, Masao Honda, Hikari Okada, Yuika Innami, Atsumu Yamada, Tetsuro Shimakami, Kazunori Kawaguchi, Taro Yamashita, Yoshio Sakai, Shuichi Kaneko |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/83d1978205734f18b3659fe9a8becfb7 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Emerging Strategies for the Management of Atherogenic Dyslipidaemia
por: Anandita Agarwala, et al.
Publicado: (2020) -
New Perspectives on Atherogenic Dyslipidaemia and Cardiovascular Disease
por: Alberto J Lorenzatti, et al.
Publicado: (2020) -
Eight-year longitudinal study of whole blood gene expression profiles in individuals undergoing long-term medical follow-up
por: Yoshio Sakai, et al.
Publicado: (2021) -
Hibernating brown bears are protected against atherogenic dyslipidemia
por: Sylvain Giroud, et al.
Publicado: (2021) -
Pathophysiological rationale for the results of atherogenic dyslipidemia simulation in rats
por: V. G. Banzaraksheev
Publicado: (2016)